Related Experiment Video
Updated: Aug 20, 2026

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
[Docosahexaenoic acid attenuated palmitate-induced insulin resistance in C2C12 cells]
Richeng Yu1, Jianhua Luo1, Ruiping Yu1
1Department of Endocrinology, Guizhou Provincial People's Hospital, Guiyang 550000, China.
Objective:
To explore the effects of docosahexaenoic acid (DHA) on palmitate-induced insulin resistance in C2C12 cells.
Methods:
Differentiated C2C12 myotubes were used. The gene expression of inflammatory cytokine and insulin signaling pathway were evaluated by quantitative polymerase chain reaction (qPCR) and Western blot. And glucose uptake was measured by [(3)H]-2DG uptake. The levels of reactive oxygen species (ROS) were evaluated by DCF fluorescence. And the activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) were measured with a glutathione assay kit.
Results:
Palmitate-induced cellular insulin resistance was clarified by reduced [(3)H]-2DG uptake and impaired gene expression of insulin signaling pathway (GLUT4, p-IRβ and p-IRS-1). DHA decreased the expression of palmitate-caused pro-inflammatory cytokines (MCP-1, IL-6 and iNOS) and oxidative stress and increased the gene expression of insulin signaling pathway (Glut4 and p-IRβ).
Conclusion:
Palmitate-induced insulin resistance is accompanied by elevated pro-inflammatory cytokines, oxidative stress and impaired gene expression of insulin signaling pathway. And DHA decreases inflammation and oxidative stress and increases glucose uptake in C2C12 cells. Thus DHA attenuates palmitate-induced insulin resistance.
More Related Videos
11:03Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes
Published on: September 9, 2021
08:20Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
Published on: December 2, 2022
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Type II Diabetes II: Pathophysiology